Posts tagged Funding
BenevolentAI raises $115 million to extend its leading global position in the field of AI enabled drug development

BenevolentAI raises $115 million, now valued at $2 billion. Funds raised to significantly scale BenevolentAI drug development activities, broaden the disease areas on which it focuses, and extend its AI platform capabilities

Read More
BenevolentAI, the pioneering London-based company using artificial intelligence to advance pharmaceutical development, appoints head of BBSRC as new Chief Executive

Jackie Hunter PhD CBE FBPharmacolS FMedSci, currently the Chief Executive of the Biotechnology and Biological Sciences Research Council (BBSRC), announced today that she will leave the BBSRC to become CEO of BenevolentBio, a business unit of BenevolentAI, a pioneering London-based technology company that applies artificial intelligence to transform the process of drug discovery in the pharmaceutical industry. 

Read More